Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Racial and Economic Gap in Awareness of Lifesaving HPV Vaccine

Published: Monday, June 10, 2013
Last Updated: Monday, June 10, 2013
Bookmark and Share
Research finds worrisome racial, economic, educational, and gender gaps in awareness about the lifesaving vaccine for HPV.

The study is being presented at the 2013 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

HPV is a primarily sexually transmitted virus most widely known for causing cervical cancer, but it can also cause anal cancer, certain oral cancers, and cancers of the sexual organs of both women and men.

Two vaccines currently exist to prevent HPV infection, and national guidelines exist for their use in men and women up to the age of 26.

Until now, however, data were lacking about awareness of the vaccines. The Yale researchers gathered data from the National Health Interview Survey, which is conducted annually by the Centers for Disease Control (CDC). The 2010 survey of more than 20,000 people between the ages of 18 and 64 provided a great deal of data about HPV awareness.

The researchers found many gaps in awareness about the lifesaving potential of HPV vaccines.

Among the findings:

•    68.1% of women had heard about the vaccine, but just 34% of men;
•    57.8% of whites surveyed were aware of the vaccine, but only 46.1% of blacks, 36% of Asians, and 32.5% of Hispanics;
•    57.8% of those with private insurance were aware, but only 36.2% of those covered by Medicare, and 37.6% of those with no health insurance;
•    72.2% of those with doctorate degrees and 61% of those with bachelors degrees were aware, but only 28.2% of those who did not complete high school;
•    62.7% of families with an income above $100,000 were aware of the vaccines, but only 41.9% of those with an income under $35,000

Even among girls aged 18-26 for whom the CDC recommends vaccination, race, ethnicity, education, and insurance remained independent predictors of awareness. All else being equal:

•    Hispanics were less than a third as aware of the vaccines as non-Hispanic whites;
•    Those with private insurance were nearly twice as aware of the vaccine as those who were uninsured;
•    Those with an associate’s or bachelor’s degree were 2.5 times more aware of the vaccine than those with less than a high school education.

Yale investigators hope that these data will inform public health strategies to improve awareness of HPV vaccination that could lower cervical cancer rates.

“In an era when such tremendous advances have been made, and we can prevent cancer with vaccines, it is unfathomable that such differences exist in the simple awareness of these vaccines based on racial, ethnic, and socioeconomic disparities. We have got to do better,” said senior author Anees Chagpar, M.D., associate professor of surgery at Yale School of Medicine and the assistant director for diversity and health equity at Yale Cancer Center.

"Awareness is the first step to prevention,” said first author and lead presenter Abigail Shrader. “With such a disastrous infection as HPV, the lack of knowledge among different subsets of the population is astonishing. The effective vaccines that our heroic doctors create are worth nothing if someone infected is unaware of the existence or effectiveness of these drugs. Increasing awareness is the first and simplest step in the right direction, and by analyzing the data from past surveys, we can now target our efforts to those who lack the most information."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Reduced Immune Response Causes Flu Deaths in Older Adults
Yale study suggests that immune response to flu causes death in older people, not the virus.
Friday, April 22, 2016
CNS Inflammation: A Pathway and Possible Drug Target
Scientists have long known that the central nervous system (CNS) has a remarkable ability to limit excessive inflammation in the presence of antigens or injury, but how it works has been unclear.
Tuesday, April 12, 2016
Nanogel That Delivers One-Two Punch To Cancer Heads To Clinical Trial
Yale scientists create a nanogel which can be used to deliver multiple drugs to cancer cells.
Wednesday, April 06, 2016
Chaos, Hope, And The Lupus Butterfly Theory
The lupus butterfly theory suggests that antibodies that attack DNA in lupus may be sources of both chaos and hope.
Wednesday, April 06, 2016
Life-Extending Hormone Bolsters Immunity
A hormone that extends lifespan in mice by 40% is produced by specialized cells in the thymus gland, according to a new study by Yale School of Medicine researchers.
Wednesday, January 13, 2016
Novel Technique for Kidney Research Developed
To better understand how the treatment leads to kidney damage, and possibly prevent it, a team of researchers at Yale School of Medicine developed a new 3D-imaging technique to peer deep into these vital organs.
Thursday, August 27, 2015
Shedding Light On Century-Old Biochemical Mystery
Yale scientists have used magnetic resonance measurements to show how glucose is metabolized in yeast to answer the puzzle of the “Warburg Effect.”
Thursday, August 20, 2015
Gene Testing Now Allows Precision Medicine for Thoracic Aneurysms
Researchers at the Aortic Institute at Yale have tested the genomes of more than 100 patients with thoracic aortic aneurysms, a potentially lethal condition, and provided genetically personalized care.
Monday, July 20, 2015
Creating More Potent Vaccines
Yale researchers uncovered a new role for a type of immune cell, known as regulatory T cells, in promoting long-term immunity.
Wednesday, July 08, 2015
Yale Team finds why BRCA Gene Resists Cancer Treatment
The University researchers have discovered why a key molecular assistant is crucial to the function of the BRCA2 gene.
Tuesday, July 07, 2015
New Type of Drug Can Target All Disease-causing Proteins
Current drugs block the actions of only about a quarter of known disease-causing proteins, but Yale University researchers have developed a technology capable of not just inhibiting, but destroying every protein it targets.
Monday, June 15, 2015
After a Sip of Milkshake, Genes and Brain Activity Predict Weight Gain
The new study published in The Journal Neuroscience.
Thursday, May 21, 2015
Researchers Solve Multiple Sclerosis Puzzle
Yale study shows the role that T cells play in MS.
Monday, May 18, 2015
Gene Editing Corrects Mutation In Cystic Fibrosis
Yale researchers successfully corrected the most common mutation in the gene that causes cystic fibrosis, a lethal genetic disorder.
Monday, April 27, 2015
New Tool To Explore Mysteries Of The Immune System
Yale scientists use CyTOF to study a range of conditions.
Monday, April 20, 2015
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!